Advertisement
Canada markets close in 3 hours 40 minutes

  • S&P/TSX

    21,983.45
    +98.07 (+0.45%)
     

  • S&P 500

    5,102.34
    +53.92 (+1.07%)
     

  • DOW

    38,247.95
    +162.15 (+0.43%)
     

  • CAD/USD

    0.7314
    -0.0009 (-0.12%)
     

  • CRUDE OIL

    84.05
    +0.48 (+0.57%)
     

  • Bitcoin CAD

    86,921.97
    -588.74 (-0.67%)
     

  • CMC Crypto 200

    1,323.58
    -72.96 (-5.23%)
     

  • GOLD FUTURES

    2,348.60
    +6.10 (+0.26%)
     

  • RUSSELL 2000

    1,998.20
    +17.08 (+0.86%)
     

  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     

  • NASDAQ

    15,928.07
    +316.31 (+2.03%)
     

  • VOLATILITY

    15.31
    -0.06 (-0.39%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Aurora Cannabis and Tilray to Supply Experimental French Medical Cannabis Program

Rich Duprey, The Motley Fool
·2 min read
Aurora Cannabis and Tilray to Supply Experimental French Medical Cannabis Program

Aurora Cannabis (NYSE: ACB) and Tilray (NASDAQ: TLRY) were among a handful of international marijuana producers chosen to participate in a new French medical marijuana experiment. The National Agency for Medicines and Health Products Safety (ANSM) is trialing a small-scale, 18- to 24-month program to supply patients with medical marijuana free of charge. Partnering with a France-based pharmaceutical establishment, producers will supply up to 3,000 patients with free product while complying with pharmaceutical standards, including Good Manufacturing Practices (GMP).

Continue reading